"Metabolic aspects" in inflammatory bowel diseases

Area of Science:

• Gastroenterology and Immunology
• Metabolic Research

Background:

• Mesenteric fat hypertrophy (
• creeping fat
• ) is common in inflammatory bowel diseases (IBD), particularly Crohn's disease.
• This adipose tissue releases pro-inflammatory cytokines and adipocytokines like leptin and adiponectin.
• The precise role of adiponectin in intestinal inflammation remains unclear, with some studies suggesting pro-inflammatory effects.

Purpose of the Study:

• To explore the biological relevance of mesenteric fat hypertrophy in IBD.
• To investigate the potential links between metabolic pathways and intestinal inflammation in Crohn's disease.

Main Methods:

• Review of existing literature on mesenteric fat, adipocytokines, autophagy, and endoplasmic reticulum (ER) stress in IBD.
• Analysis of experimental studies involving ATG16L1-deficient mice and ER stress/XBP1 pathways.

Main Results:

• ATG16L1 deficiency in mice is associated with increased adiponectin and leptin expression.
• Autophagy and ER stress pathways are implicated in both intestinal inflammation and lipid metabolism.
• The XBP1 pathway, involved in ER stress, regulates fatty acid synthesis and adipogenesis.

Conclusions:

• Metabolic factors, including adipocytokines, autophagy, and ER stress, are crucial in IBD pathogenesis.
• The XBP1 pathway may link intestinal inflammation with mesenteric fat development in Crohn's disease.
• Further research into these metabolic aspects is warranted for understanding and treating IBD.